Sterility test and procedures

Microbial Contamination Control in the Pharmaceutical Industry

Volumn , Issue , 2004, Pages 77-102

  Jimenez, Luis ^a  

^a Genomic Profiling Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37349024597     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (40)

1. United States Pharmacopeial Convention. Sterilization and sterility assurance of compendial articles. US Pharmacopoeia. Vol. 25. Rockville, MD: United States Pharmacopeial Convention, 2002;2250-2255.
2. European Pharmacopoeial Convention. Sterility. European Pharmacopoeia. 3rd ed. Strasbourg, France: Council of Europe, 2001;63-67.
3. Parenteral Drug Association. Aseptic processing; how good science and good manufacturing practices can prevent contamination. PDA Lett 2002; 38:10-11.
4. FDC Reports. Quality control reports “The Gold Sheet.” 1998; 32(1).
5. FDC Reports. Quality control reports “The Gold Sheet.” 1997; 31(1).
6. FDC Reports. Quality control reports “The Gold Sheet.” 1999; 33(8).
7. FDC Reports. Quality control reports “The Gold Sheet.” 2000; 34(2).
8. FDC Reports. Quality control reports “The Gold Sheet.” 2001; 35(3).
9. FDC Reports. Quality control reports “The Gold Sheet.” 2002; 36(3).
10. FDC Reports. Quality control reports “The Gold Sheet.” 2003; 37(3).
11. Parenteral Drug Association. PDA testifies before FDA pharmaceutical advisory committee. PDA Lett 2002; 38(1):12-15.
12. Anderson RL, Bland LA, Favero MS, McNeil MM, Davis BJ, Mackel DC, Gravelle CR. Factors associated with Pseudomonas picketti intrinsic contamination of commercially respiratory therapy solutions marketed as sterile. Appl Environ Microbiol 1985; 50:1343-1348.
13. Roberts LA, Collignon PJ, Cramp VB, Alexander S, McFarlane AE, Graham E, Fuller A, Sinickas V, Hellyar A. An Australia-wide epidemic of Pseudomonas picketti bacteraemia due to contaminated “sterile’' water for injection. Med J Aust 1990; 152:652-655.
14. McNeil MM, Solomon SL, Anderson RL, Davis BJ, Spengler RF, Reisberg BE, Thornsberry C, Martone WJ. Nosocomial Pseudomonas picketti colonization associated with a contaminated respiratory therapy solution in a special care nursery. J Clin Microbiol 1985; 22:903-907.
15. Akers JE, Agalloco JP. Aseptic processing, elephants, blind men, and sterility. PDA J Sci Technol 2002; 56:231-234.
16. Pflug IJ. Microbiology and Engineering of Sterilization Processes. Minneapolis, MN: University of Minnesota, 1995.
17. Hugo WB. Bacteria. In: Hugo WB, Russell AB, eds. Pharmaceutical Microbiology. 6th ed. Oxford, England: Blackwell Science, 1998;3-34.
18. United States Pharmacopeial Convention. Bacterial endotoxin test. US Pharmacopoeia. Vol. 26. Rockville, MD: United States Pharmacopeial Convention, 2003;2023-2026.
19. Levy RV. Sterilizing filtration of liquids. In: Prince R, ed. Microbiology in Pharmaceutical Manufacturing. 1st ed. Baltimore, MD, USA/Surrey, UK:PDA/Davis-Horwood International Publishing Limited, 2001;399-412.
20. Sundaram S, Eisenhuth J, Howard G, Brandwein H. Method for qualifying microbial removal performance of 0.1 micron rated filters: Part I. Characterization of water isolates for potential use as standard challenge organisms to qualify 0.1 micron rated filters. PDA J Pharm Sci Technol 2001; 55:346-372.
21. Sundaram S, Mallick S, Eisenhuth J, Howard G, Brandwein H. Retention of water-borne bacteria by membrane filters: Part II. Scanning electron microscopy (SEM) and fatty acid methyl ester (FAME) characterization of bacterial species recovered downstream of 0.2/0.22 micron rated filters. PDA J Pharm Sci Technol 2001; 55:87-113.
22. Sundaram S, Eisenhuth J, Lewis M, Howard G, Brandwein H. Method for qualifying microbial removal performance of 0.1 micron rated filters: Part III. Bacterial challenge tests on 0.2/0.22 and 0.1 micron rated filter cartridges with Hydrogenophaga (formerly Pseudomonas) pseudoflava. PDA J Pharm Sci Technol 2001; 55:393-416.
23. Jornitz MW, Soelkner PG, Meltzer TH. Sterile-filtration-a review of the past and present technologies. PDA J Sci Technol 2002; 56:192-195.
24. Pflug IJ, Evans KD. Carrying out the biological qualification: the control operation of moist-heat (steam sterilization) processes for producing sterile pharmaceuticals and medical devices. PDA J Sci Technol 2000; 54:117-135.
25. Pflug IJ, Odlaug TE. Biological indicators in the pharmaceutical and the medical device industry. J Parenter Sci Technol 1986; 40:249-255.
26. Cristina de Oliveira D, de Jesus Andreoli Pinto T. Study of sterilizing effectivity of different Ethylene Oxide gaseous mixtures using CFCs and HFCs (Oxyfume 12R and 2002R). PDA J Sci Technol 2002; 56:242-247.
27. United States Pharmacopeial Convention. Microbiological evaluation of clean rooms and other controlled environments. US Pharmacopoeia. Vol. 25. Rockville, MD: United States Pharmacopeial Convention, 2002;2206-2212.
28. Underwood E. Ecology of microorganisms as its affects the pharmaceutical industry. In: Hugo WB, Russell AB, eds. Pharmaceutical Microbiology. 6th ed. Oxford, England: Blackwell Science, 1998;339-354.
29. Hyde W. Origin of bacteria in the clean room and their growth requirements. PDA J Sci Technol 1998; 52:154-164.
30. The Japanese Pharmacopoeia. Media Fill Test. 14th ed. Tokyo, Japan: The Society of Japanese Pharmacopoeia, 2001;212-215.
31. Van Doorne H, Van Kampen BJ, Van der Lee RW, Rummenie L, Van der Veen AJ, De Vries WJ. Industrial manufacture of parenteral products in The Netherlands. A survey of eight years of media fills and sterility testing. PDA J Pharm Sci Technol 1998; 52:159-164.
32. Kawamura K, Abe H. Consideration of media fill test for evaluation and control of aseptic processes: a statistical approach to quality criteria. PDA J Sci Technol 2002; 56:235-241.
33. United States Pharmacopeial Convention. Sterility tests. US Pharmacopoeia. Vol. 25. Rockville, MD: United States Pharmacopeial Convention, 2002;1878-1883.
34. The Japanese Pharmacopoeia. Sterility test. 13th ed. Tokyo, Japan: The Society of Japanese Pharmacopoeia, 1996;69-71.
35. Besajew C. Importance of incubation time in the test for sterility. Pharm Ind 1992; 54:539-542.
36. Cundell AM. Review of the media selection and incubation conditions for the compendial sterility and microbial limit tests. Pharm Forum 2002; 28:2034-2041.
37. Christianson GG, Koski TA. A comparison of a disposable membrane filtration system with a direct inoculation system for sterility testing of veterinary biologics. J Biol Stand 1983; 11:83-89.
38. Proud DW, Sutton SV. Development of a universal diluting fluid for membrane filtration sterility testing. Appl Environ Microbiol 1992; 58:1035-1038.
39. d’Arbelloff N. Improving integrity of pharmaceutical sterility testing: a new robotic approach. Drug Dev Ind Pharm 1988; 14:2733-2740.
40. United States Pharmacopeial Convention. Sterility testing-validation of isolator systems. US Pharmacopoeia. Vol. 25. Rockville, MD: United States Pharmacopeial Convention, 2002;2247-2249.